Dr. Monika Emilia Richter - McDermott Will & Emery


Dr. Monika Richter advises national and international biotechnology/pharmaceuticals companies on various commercial legal matters related to the development, manufacturing and commercialization of medicinal products, with a particular focus on strategic alliances, research and development collaborations, license agreements, commercial manufacturing and supply agreements and distribution agreements. Her work likewise includes financing and corporate transactions as well as mergers and acquisitions.

Given her Polish background, Monika Richter is active in the Eastern European market, regularly speaking at industry conferences in Poland and advising Polish clients on several cross-border collaborations in the life sciences sector.


Monika advised:

  • Ryvu Therapeutics (formerly named Selvita), one of Poland’s largest biotechnology companies, on an exclusive license agreement with Exelixis and on various other international licensing and collaboration agreements, including with Orion Pharma, H3, Felicitex, Merck, and Menarini, and on a funding agreement with the Leukemia and Lymphoma Society
  • Moffitt Cancer Center, a world leader in advancing cellular immunotherapies for the treatment of cancer, in its strategic alliance with Turnstone Biologics
  • Paion on license agreements for the development and commercialization of Remimazolam in various territories, e.g., with Cristalia Produtos Quimicos Farmaceuticos (Brazil), Mundipharma (Japan), and TTY (Taiwan), as well as on various distribution agreements and commercial manufacturing and supply agreements regarding Remimazolam and other products

Show More


  • Thomson Reuters, “Stand-out Lawyer” – independently rated lawyers, 2023-2024
  • The Legal 500 EMEA, “Rising Star” in Germany: Healthcare and Life Sciences, 2024
  • The Best Lawyers in Germany, Biotechnology Law, Life Sciences Practice, Mergers and Acquisitions Law, 2021 to 2024
  • The Legal 500 EMEA, 2022-2023
  • Leaders League’ 2019 Guide: Innovation, Technology & Patents, “Excellent”: Health, Pharma & Biotechnology


Humboldt University of Berlin, Dr. jur., 2008
Court of Appeal (Kammergericht), Berlin, Second State Exam, 2004
Universities of Tübingen and Heidelberg, First State Exam, 2002


Show More